nodes	percent_of_prediction	percent_of_DWPC	metapath
Valganciclovir—SLC15A2—Fosinopril—hypertension	0.055	0.0808	CbGbCtD
Valganciclovir—SLC15A2—Quinapril—hypertension	0.055	0.0808	CbGbCtD
Valganciclovir—SLC15A2—Benazepril—hypertension	0.049	0.072	CbGbCtD
Valganciclovir—SLC15A2—Moexipril—hypertension	0.049	0.072	CbGbCtD
Valganciclovir—SLC15A1—Fosinopril—hypertension	0.0473	0.0696	CbGbCtD
Valganciclovir—SLC15A1—Quinapril—hypertension	0.0473	0.0696	CbGbCtD
Valganciclovir—SLC15A1—Methyldopa—hypertension	0.0422	0.062	CbGbCtD
Valganciclovir—SLC15A1—Benazepril—hypertension	0.0422	0.062	CbGbCtD
Valganciclovir—SLC15A1—Moexipril—hypertension	0.0422	0.062	CbGbCtD
Valganciclovir—SLC15A2—Trandolapril—hypertension	0.0371	0.0546	CbGbCtD
Valganciclovir—SLC15A2—Perindopril—hypertension	0.0339	0.0499	CbGbCtD
Valganciclovir—SLC15A1—Trandolapril—hypertension	0.032	0.047	CbGbCtD
Valganciclovir—SLC15A1—Perindopril—hypertension	0.0292	0.043	CbGbCtD
Valganciclovir—SLC15A2—Ramipril—hypertension	0.0281	0.0413	CbGbCtD
Valganciclovir—SLC15A1—Lisinopril—hypertension	0.0242	0.0356	CbGbCtD
Valganciclovir—SLC15A1—Ramipril—hypertension	0.0242	0.0356	CbGbCtD
Valganciclovir—SLC15A1—Enalapril—hypertension	0.0242	0.0356	CbGbCtD
Valganciclovir—SLC15A1—Captopril—hypertension	0.0181	0.0267	CbGbCtD
Valganciclovir—SLC6A14—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—hypertension	0.000602	0.00677	CbGpPWpGaD
Valganciclovir—SLC6A14—NRF2 pathway—GSTM5—hypertension	0.000591	0.00665	CbGpPWpGaD
Valganciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC12A1—hypertension	0.000578	0.00651	CbGpPWpGaD
Valganciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC12A3—hypertension	0.000578	0.00651	CbGpPWpGaD
Valganciclovir—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC12A1—hypertension	0.000568	0.00639	CbGpPWpGaD
Valganciclovir—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC12A3—hypertension	0.000568	0.00639	CbGpPWpGaD
Valganciclovir—SLC6A14—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC8A1—hypertension	0.000556	0.00626	CbGpPWpGaD
Valganciclovir—SLC6A14—NRF2 pathway—CYP4A11—hypertension	0.000482	0.00543	CbGpPWpGaD
Valganciclovir—SLC6A14—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—hypertension	0.000471	0.0053	CbGpPWpGaD
Valganciclovir—SLC6A14—NRF2 pathway—SLC5A2—hypertension	0.000464	0.00522	CbGpPWpGaD
Valganciclovir—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC4A4—hypertension	0.000464	0.00522	CbGpPWpGaD
Valganciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC6A2—hypertension	0.000462	0.0052	CbGpPWpGaD
Valganciclovir—SLC6A14—NRF2 pathway—SOD3—hypertension	0.000448	0.00504	CbGpPWpGaD
Valganciclovir—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC6A18—hypertension	0.000442	0.00498	CbGpPWpGaD
Valganciclovir—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC6A19—hypertension	0.000442	0.00498	CbGpPWpGaD
Valganciclovir—SLC6A14—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRB—hypertension	0.000438	0.00493	CbGpPWpGaD
Valganciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC4A4—hypertension	0.000438	0.00493	CbGpPWpGaD
Valganciclovir—SLC6A14—NRF2 pathway—SLC2A3—hypertension	0.000434	0.00488	CbGpPWpGaD
Valganciclovir—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC4A4—hypertension	0.00043	0.00485	CbGpPWpGaD
Valganciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC6A18—hypertension	0.000418	0.00471	CbGpPWpGaD
Valganciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC6A19—hypertension	0.000418	0.00471	CbGpPWpGaD
Valganciclovir—SLC6A14—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC9A1—hypertension	0.000416	0.00469	CbGpPWpGaD
Valganciclovir—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC6A18—hypertension	0.000411	0.00462	CbGpPWpGaD
Valganciclovir—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC6A19—hypertension	0.000411	0.00462	CbGpPWpGaD
Valganciclovir—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC9A3—hypertension	0.000351	0.00396	CbGpPWpGaD
Valganciclovir—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC12A2—hypertension	0.000351	0.00396	CbGpPWpGaD
Valganciclovir—SLC6A14—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—hypertension	0.000335	0.00378	CbGpPWpGaD
Valganciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC9A3—hypertension	0.000332	0.00374	CbGpPWpGaD
Valganciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC12A2—hypertension	0.000332	0.00374	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—CLCNKB—hypertension	0.00033	0.00371	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—CLCNKA—hypertension	0.00033	0.00371	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—SCNN1G—hypertension	0.00033	0.00371	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—WNK1—hypertension	0.00033	0.00371	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—SCNN1B—hypertension	0.00033	0.00371	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—WNK4—hypertension	0.00033	0.00371	CbGpPWpGaD
Valganciclovir—SLC6A14—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A4—hypertension	0.000326	0.00367	CbGpPWpGaD
Valganciclovir—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC9A3—hypertension	0.000326	0.00367	CbGpPWpGaD
Valganciclovir—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC12A2—hypertension	0.000326	0.00367	CbGpPWpGaD
Valganciclovir—SLC6A14—NRF2 pathway—TGFA—hypertension	0.000324	0.00365	CbGpPWpGaD
Valganciclovir—SLC6A14—NRF2 pathway—GPX3—hypertension	0.000324	0.00365	CbGpPWpGaD
Valganciclovir—SLC6A14—NRF2 pathway—SERPINA1—hypertension	0.000319	0.00359	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—SLC12A3—hypertension	0.000294	0.00331	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—FXYD2—hypertension	0.000294	0.00331	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—AQP2—hypertension	0.000294	0.00331	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—SLC12A1—hypertension	0.000294	0.00331	CbGpPWpGaD
Valganciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC5A2—hypertension	0.000292	0.00329	CbGpPWpGaD
Valganciclovir—SLC6A14—NRF2 pathway—GCLC—hypertension	0.000292	0.00329	CbGpPWpGaD
Valganciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC12A1—hypertension	0.000273	0.00308	CbGpPWpGaD
Valganciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC12A3—hypertension	0.000273	0.00308	CbGpPWpGaD
Valganciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC2A3—hypertension	0.000273	0.00308	CbGpPWpGaD
Valganciclovir—SLC6A14—NRF2 pathway—SLC6A4—hypertension	0.000271	0.00306	CbGpPWpGaD
Valganciclovir—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC8A1—hypertension	0.000263	0.00296	CbGpPWpGaD
Valganciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC12A3—hypertension	0.000254	0.00286	CbGpPWpGaD
Valganciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC12A1—hypertension	0.000254	0.00286	CbGpPWpGaD
Valganciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC8A1—hypertension	0.000249	0.0028	CbGpPWpGaD
Valganciclovir—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC8A1—hypertension	0.000244	0.00275	CbGpPWpGaD
Valganciclovir—SLC6A14—NRF2 pathway—SLC6A3—hypertension	0.000242	0.00272	CbGpPWpGaD
Valganciclovir—SLC6A14—NRF2 pathway—SLC2A4—hypertension	0.000235	0.00265	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—SLC6A2—hypertension	0.000235	0.00264	CbGpPWpGaD
Valganciclovir—SLC6A14—NRF2 pathway—EGR1—hypertension	0.000228	0.00257	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—ATP2B3—hypertension	0.000223	0.00251	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—TRPC5—hypertension	0.000223	0.00251	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—ATP1A2—hypertension	0.000223	0.00251	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—SLC4A4—hypertension	0.000223	0.00251	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—ATP1A1—hypertension	0.000223	0.00251	CbGpPWpGaD
Valganciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC6A2—hypertension	0.000219	0.00246	CbGpPWpGaD
Valganciclovir—SLC6A14—SLC-mediated transmembrane transport—CP—hypertension	0.000214	0.00241	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—SCNN1A—hypertension	0.000212	0.00239	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—SLC6A18—hypertension	0.000212	0.00239	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—SLC6A19—hypertension	0.000212	0.00239	CbGpPWpGaD
Valganciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC4A4—hypertension	0.000207	0.00233	CbGpPWpGaD
Valganciclovir—SLC6A14—NRF2 pathway—TGFBR2—hypertension	0.000205	0.0023	CbGpPWpGaD
Valganciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC6A2—hypertension	0.000203	0.00228	CbGpPWpGaD
Valganciclovir—SLC6A14—NRF2 pathway—HMOX1—hypertension	0.000202	0.00227	CbGpPWpGaD
Valganciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC6A18—hypertension	0.000198	0.00223	CbGpPWpGaD
Valganciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC6A19—hypertension	0.000198	0.00223	CbGpPWpGaD
Valganciclovir—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC9A1—hypertension	0.000197	0.00222	CbGpPWpGaD
Valganciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC4A4—hypertension	0.000192	0.00217	CbGpPWpGaD
Valganciclovir—SLC6A14—NRF2 pathway—GSTM1—hypertension	0.000188	0.00212	CbGpPWpGaD
Valganciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC9A1—hypertension	0.000186	0.0021	CbGpPWpGaD
Valganciclovir—SLC6A14—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—hypertension	0.000184	0.00207	CbGpPWpGaD
Valganciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC6A18—hypertension	0.000183	0.00207	CbGpPWpGaD
Valganciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC6A19—hypertension	0.000183	0.00207	CbGpPWpGaD
Valganciclovir—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC9A1—hypertension	0.000183	0.00206	CbGpPWpGaD
Valganciclovir—SLC6A14—NRF2 pathway—AGER—hypertension	0.000181	0.00204	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—AVPR2—hypertension	0.000178	0.002	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—COX5B—hypertension	0.000178	0.002	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—ATP1B1—hypertension	0.000178	0.002	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—SLC9A3—hypertension	0.000169	0.0019	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—SLC12A2—hypertension	0.000169	0.0019	CbGpPWpGaD
Valganciclovir—SLC6A14—NRF2 pathway—PDGFB—hypertension	0.000162	0.00182	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—ABCC9—hypertension	0.000161	0.00181	CbGpPWpGaD
Valganciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC9A3—hypertension	0.000157	0.00177	CbGpPWpGaD
Valganciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC12A2—hypertension	0.000157	0.00177	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—SCNN1G—hypertension	0.000156	0.00176	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—CLCNKA—hypertension	0.000156	0.00176	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—WNK1—hypertension	0.000156	0.00176	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—CLCNKB—hypertension	0.000156	0.00176	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—WNK4—hypertension	0.000156	0.00176	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—SCNN1B—hypertension	0.000156	0.00176	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—SGK1—hypertension	0.000154	0.00174	CbGpPWpGaD
Valganciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC6A3—hypertension	0.000152	0.00172	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—SLC5A2—hypertension	0.000149	0.00167	CbGpPWpGaD
Valganciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC2A4—hypertension	0.000148	0.00167	CbGpPWpGaD
Valganciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC9A3—hypertension	0.000146	0.00164	CbGpPWpGaD
Valganciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC12A2—hypertension	0.000146	0.00164	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—CLCNKB—hypertension	0.000145	0.00163	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—SCNN1B—hypertension	0.000145	0.00163	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—WNK4—hypertension	0.000145	0.00163	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—CLCNKA—hypertension	0.000145	0.00163	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—WNK1—hypertension	0.000145	0.00163	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—SCNN1G—hypertension	0.000145	0.00163	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—ABCC1—hypertension	0.000143	0.00162	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—NEDD4L—hypertension	0.000143	0.00162	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—SLC12A3—hypertension	0.000139	0.00156	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—SLC12A1—hypertension	0.000139	0.00156	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—AQP2—hypertension	0.000139	0.00156	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—FXYD2—hypertension	0.000139	0.00156	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—SLC2A3—hypertension	0.000139	0.00156	CbGpPWpGaD
Valganciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC5A2—hypertension	0.000138	0.00156	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—ATP2B1—hypertension	0.000137	0.00154	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—ATP2A3—hypertension	0.000135	0.00152	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—AQP1—hypertension	0.000135	0.00152	CbGpPWpGaD
Valganciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC2A3—hypertension	0.000129	0.00146	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—AQP2—hypertension	0.000129	0.00145	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—SLC12A1—hypertension	0.000129	0.00145	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—FXYD2—hypertension	0.000129	0.00145	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—SLC12A3—hypertension	0.000129	0.00145	CbGpPWpGaD
Valganciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC5A2—hypertension	0.000128	0.00144	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—SLC8A1—hypertension	0.000126	0.00142	CbGpPWpGaD
Valganciclovir—SLC6A14—SLC-mediated transmembrane transport—AVP—hypertension	0.000126	0.00142	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—AQP4—hypertension	0.000122	0.00137	CbGpPWpGaD
Valganciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC2A3—hypertension	0.00012	0.00135	CbGpPWpGaD
Valganciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC8A1—hypertension	0.000118	0.00132	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—TRPC3—hypertension	0.000117	0.00132	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—SLC6A2—hypertension	0.000111	0.00125	CbGpPWpGaD
Valganciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC8A1—hypertension	0.000109	0.00123	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—CP—hypertension	0.000109	0.00122	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—TRPC5—hypertension	0.000105	0.00119	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—ATP2B3—hypertension	0.000105	0.00119	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—SLC4A4—hypertension	0.000105	0.00119	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—ATP1A1—hypertension	0.000105	0.00119	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—ATP1A2—hypertension	0.000105	0.00119	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—SLC6A2—hypertension	0.000103	0.00116	CbGpPWpGaD
Valganciclovir—SLC15A2—SLC-mediated transmembrane transport—CP—hypertension	0.000101	0.00114	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—SLC6A18—hypertension	0.0001	0.00113	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—SLC6A19—hypertension	0.0001	0.00113	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—SCNN1A—hypertension	0.0001	0.00113	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—TRPC5—hypertension	9.77e-05	0.0011	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—ATP2B3—hypertension	9.77e-05	0.0011	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—SLC4A4—hypertension	9.77e-05	0.0011	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—ATP1A1—hypertension	9.77e-05	0.0011	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—ATP1A2—hypertension	9.77e-05	0.0011	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—SLC9A1—hypertension	9.46e-05	0.00106	CbGpPWpGaD
Valganciclovir—SLC15A1—SLC-mediated transmembrane transport—CP—hypertension	9.39e-05	0.00106	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—CETP—hypertension	9.35e-05	0.00105	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—SCNN1A—hypertension	9.32e-05	0.00105	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—SLC6A18—hypertension	9.32e-05	0.00105	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—SLC6A19—hypertension	9.32e-05	0.00105	CbGpPWpGaD
Valganciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC9A1—hypertension	8.8e-05	0.000991	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—COX5B—hypertension	8.42e-05	0.000948	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—AVPR2—hypertension	8.42e-05	0.000948	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—ATP1B1—hypertension	8.42e-05	0.000948	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—PLAT—hypertension	8.24e-05	0.000928	CbGpPWpGaD
Valganciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC9A1—hypertension	8.17e-05	0.00092	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—SLC9A3—hypertension	7.98e-05	0.000898	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—SLC12A2—hypertension	7.98e-05	0.000898	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—AVPR2—hypertension	7.81e-05	0.00088	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—ATP1B1—hypertension	7.81e-05	0.00088	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—COX5B—hypertension	7.81e-05	0.00088	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—SLC6A3—hypertension	7.75e-05	0.000872	CbGpPWpGaD
Valganciclovir—SLC6A14—NRF2 pathway—TGFB1—hypertension	7.67e-05	0.000863	CbGpPWpGaD
Valganciclovir—SLC6A14—SLC-mediated transmembrane transport—ALB—hypertension	7.64e-05	0.00086	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—ABCC9—hypertension	7.61e-05	0.000857	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—SLC2A4—hypertension	7.54e-05	0.000848	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—SLC9A3—hypertension	7.41e-05	0.000834	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—SLC12A2—hypertension	7.41e-05	0.000834	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—SGK1—hypertension	7.3e-05	0.000822	CbGpPWpGaD
Valganciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC6A3—hypertension	7.21e-05	0.000812	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—ABCC9—hypertension	7.07e-05	0.000795	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—SLC5A2—hypertension	7.03e-05	0.000791	CbGpPWpGaD
Valganciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC2A4—hypertension	7.01e-05	0.00079	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—PLG—hypertension	7.01e-05	0.000789	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—NEDD4L—hypertension	6.79e-05	0.000764	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—ABCC1—hypertension	6.79e-05	0.000764	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—SGK1—hypertension	6.77e-05	0.000763	CbGpPWpGaD
Valganciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC6A3—hypertension	6.69e-05	0.000753	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—SLC2A3—hypertension	6.57e-05	0.00074	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—SLC5A2—hypertension	6.52e-05	0.000734	CbGpPWpGaD
Valganciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC2A4—hypertension	6.51e-05	0.000733	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—GNB3—hypertension	6.5e-05	0.000731	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—ATP2B1—hypertension	6.47e-05	0.000729	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—HMOX1—hypertension	6.47e-05	0.000728	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—AVP—hypertension	6.41e-05	0.000721	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—AQP1—hypertension	6.38e-05	0.000718	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—ATP2A3—hypertension	6.38e-05	0.000718	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—GNAS—hypertension	6.32e-05	0.000712	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—ABCC1—hypertension	6.3e-05	0.000709	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—NEDD4L—hypertension	6.3e-05	0.000709	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—APOB—hypertension	6.19e-05	0.000697	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—SLC2A3—hypertension	6.1e-05	0.000687	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—ATP2B1—hypertension	6.01e-05	0.000676	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—SLC8A1—hypertension	5.97e-05	0.000673	CbGpPWpGaD
Valganciclovir—SLC15A2—SLC-mediated transmembrane transport—AVP—hypertension	5.96e-05	0.000671	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—ATP2A3—hypertension	5.92e-05	0.000667	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—AQP1—hypertension	5.92e-05	0.000667	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—ADCY5—hypertension	5.79e-05	0.000652	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—AQP4—hypertension	5.77e-05	0.00065	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—SLC8A1—hypertension	5.54e-05	0.000624	CbGpPWpGaD
Valganciclovir—SLC15A1—SLC-mediated transmembrane transport—AVP—hypertension	5.54e-05	0.000623	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—TRPC3—hypertension	5.53e-05	0.000623	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—AQP4—hypertension	5.35e-05	0.000603	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—PPARA—hypertension	5.22e-05	0.000588	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—CP—hypertension	5.14e-05	0.000579	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—TRPC3—hypertension	5.13e-05	0.000578	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—APOA1—hypertension	4.9e-05	0.000552	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—CP—hypertension	4.77e-05	0.000537	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—SLC9A1—hypertension	4.47e-05	0.000504	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—CETP—hypertension	4.42e-05	0.000498	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—SLC9A1—hypertension	4.15e-05	0.000467	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—CETP—hypertension	4.1e-05	0.000462	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—PLAT—hypertension	3.9e-05	0.000439	CbGpPWpGaD
Valganciclovir—SLC6A14—Transmembrane transport of small molecules—ALB—hypertension	3.88e-05	0.000437	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—SLC6A3—hypertension	3.66e-05	0.000413	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—PLAT—hypertension	3.62e-05	0.000407	CbGpPWpGaD
Valganciclovir—SLC15A2—SLC-mediated transmembrane transport—ALB—hypertension	3.61e-05	0.000407	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—SLC2A4—hypertension	3.56e-05	0.000401	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—SLC6A3—hypertension	3.4e-05	0.000383	CbGpPWpGaD
Valganciclovir—SLC15A1—SLC-mediated transmembrane transport—ALB—hypertension	3.35e-05	0.000378	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—PLG—hypertension	3.31e-05	0.000373	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—SLC2A4—hypertension	3.31e-05	0.000372	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—PLG—hypertension	3.08e-05	0.000346	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—GNB3—hypertension	3.07e-05	0.000346	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—HMOX1—hypertension	3.06e-05	0.000344	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—AVP—hypertension	3.03e-05	0.000341	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—GNAS—hypertension	2.99e-05	0.000337	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—APOB—hypertension	2.93e-05	0.00033	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—GNB3—hypertension	2.85e-05	0.000321	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—HMOX1—hypertension	2.84e-05	0.00032	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—AVP—hypertension	2.81e-05	0.000317	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—GNAS—hypertension	2.78e-05	0.000313	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—ADCY5—hypertension	2.74e-05	0.000308	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—APOB—hypertension	2.72e-05	0.000306	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—ADCY5—hypertension	2.54e-05	0.000286	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—PPARA—hypertension	2.47e-05	0.000278	CbGpPWpGaD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—APOA1—hypertension	2.32e-05	0.000261	CbGpPWpGaD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—PPARA—hypertension	2.29e-05	0.000258	CbGpPWpGaD
Valganciclovir—Gastrointestinal pain—Furosemide—hypertension	2.27e-05	9.83e-05	CcSEcCtD
Valganciclovir—Urticaria—Perindopril—hypertension	2.27e-05	9.82e-05	CcSEcCtD
Valganciclovir—Headache—Fosinopril—hypertension	2.27e-05	9.82e-05	CcSEcCtD
Valganciclovir—Hypersensitivity—Trandolapril—hypertension	2.27e-05	9.82e-05	CcSEcCtD
Valganciclovir—Dermatitis—Eplerenone—hypertension	2.27e-05	9.82e-05	CcSEcCtD
Valganciclovir—Diarrhoea—Valsartan—hypertension	2.27e-05	9.81e-05	CcSEcCtD
Valganciclovir—Asthenia—Clonidine—hypertension	2.26e-05	9.81e-05	CcSEcCtD
Valganciclovir—Feeling abnormal—Betaxolol—hypertension	2.26e-05	9.81e-05	CcSEcCtD
Valganciclovir—Confusional state—Timolol—hypertension	2.26e-05	9.8e-05	CcSEcCtD
Valganciclovir—Vomiting—Verapamil—hypertension	2.26e-05	9.79e-05	CcSEcCtD
Valganciclovir—Urticaria—Irbesartan—hypertension	2.26e-05	9.79e-05	CcSEcCtD
Valganciclovir—Hypersensitivity—Enalapril—hypertension	2.26e-05	9.78e-05	CcSEcCtD
Valganciclovir—Abdominal pain—Perindopril—hypertension	2.26e-05	9.78e-05	CcSEcCtD
Valganciclovir—Body temperature increased—Perindopril—hypertension	2.26e-05	9.78e-05	CcSEcCtD
Valganciclovir—Diarrhoea—Olmesartan—hypertension	2.25e-05	9.77e-05	CcSEcCtD
Valganciclovir—Headache—Eplerenone—hypertension	2.25e-05	9.76e-05	CcSEcCtD
Valganciclovir—Nervous system disorder—Ramipril—hypertension	2.25e-05	9.75e-05	CcSEcCtD
Valganciclovir—Dermatitis—Nifedipine—hypertension	2.25e-05	9.75e-05	CcSEcCtD
Valganciclovir—Abdominal pain—Irbesartan—hypertension	2.25e-05	9.74e-05	CcSEcCtD
Valganciclovir—Body temperature increased—Irbesartan—hypertension	2.25e-05	9.74e-05	CcSEcCtD
Valganciclovir—Thrombocytopenia—Ramipril—hypertension	2.25e-05	9.74e-05	CcSEcCtD
Valganciclovir—Oedema—Timolol—hypertension	2.24e-05	9.72e-05	CcSEcCtD
Valganciclovir—Anaphylactic shock—Timolol—hypertension	2.24e-05	9.72e-05	CcSEcCtD
Valganciclovir—Urticaria—Hydrochlorothiazide—hypertension	2.24e-05	9.71e-05	CcSEcCtD
Valganciclovir—Tachycardia—Ramipril—hypertension	2.24e-05	9.71e-05	CcSEcCtD
Valganciclovir—Dermatitis—Verapamil—hypertension	2.24e-05	9.7e-05	CcSEcCtD
Valganciclovir—Headache—Nifedipine—hypertension	2.24e-05	9.69e-05	CcSEcCtD
Valganciclovir—Pruritus—Clonidine—hypertension	2.23e-05	9.67e-05	CcSEcCtD
Valganciclovir—Abdominal pain—Hydrochlorothiazide—hypertension	2.23e-05	9.66e-05	CcSEcCtD
Valganciclovir—Body temperature increased—Hydrochlorothiazide—hypertension	2.23e-05	9.66e-05	CcSEcCtD
Valganciclovir—Skin disorder—Ramipril—hypertension	2.23e-05	9.66e-05	CcSEcCtD
Valganciclovir—Infection—Timolol—hypertension	2.23e-05	9.66e-05	CcSEcCtD
Valganciclovir—Headache—Verapamil—hypertension	2.23e-05	9.65e-05	CcSEcCtD
Valganciclovir—Hypersensitivity—Telmisartan—hypertension	2.23e-05	9.65e-05	CcSEcCtD
Valganciclovir—Cough—Lisinopril—hypertension	2.23e-05	9.64e-05	CcSEcCtD
Valganciclovir—Nausea—Indapamide—hypertension	2.22e-05	9.63e-05	CcSEcCtD
Valganciclovir—Nausea—Diltiazem—hypertension	2.22e-05	9.63e-05	CcSEcCtD
Valganciclovir—Hyperhidrosis—Ramipril—hypertension	2.22e-05	9.62e-05	CcSEcCtD
Valganciclovir—Asthenia—Trandolapril—hypertension	2.21e-05	9.57e-05	CcSEcCtD
Valganciclovir—Feeling abnormal—Losartan—hypertension	2.21e-05	9.56e-05	CcSEcCtD
Valganciclovir—Urticaria—Furosemide—hypertension	2.21e-05	9.55e-05	CcSEcCtD
Valganciclovir—Nervous system disorder—Timolol—hypertension	2.2e-05	9.54e-05	CcSEcCtD
Valganciclovir—Nausea—Carvedilol—hypertension	2.2e-05	9.53e-05	CcSEcCtD
Valganciclovir—Asthenia—Enalapril—hypertension	2.2e-05	9.53e-05	CcSEcCtD
Valganciclovir—Body temperature increased—Furosemide—hypertension	2.19e-05	9.5e-05	CcSEcCtD
Valganciclovir—Abdominal pain—Furosemide—hypertension	2.19e-05	9.5e-05	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Losartan—hypertension	2.19e-05	9.49e-05	CcSEcCtD
Valganciclovir—Dizziness—Valsartan—hypertension	2.19e-05	9.48e-05	CcSEcCtD
Valganciclovir—Anorexia—Ramipril—hypertension	2.19e-05	9.48e-05	CcSEcCtD
Valganciclovir—Urticaria—Betaxolol—hypertension	2.18e-05	9.46e-05	CcSEcCtD
Valganciclovir—Skin disorder—Timolol—hypertension	2.18e-05	9.44e-05	CcSEcCtD
Valganciclovir—Dizziness—Olmesartan—hypertension	2.18e-05	9.44e-05	CcSEcCtD
Valganciclovir—Pruritus—Trandolapril—hypertension	2.18e-05	9.43e-05	CcSEcCtD
Valganciclovir—Nausea—Doxazosin—hypertension	2.18e-05	9.43e-05	CcSEcCtD
Valganciclovir—Arthralgia—Lisinopril—hypertension	2.17e-05	9.41e-05	CcSEcCtD
Valganciclovir—Body temperature increased—Betaxolol—hypertension	2.17e-05	9.41e-05	CcSEcCtD
Valganciclovir—Hyperhidrosis—Timolol—hypertension	2.17e-05	9.4e-05	CcSEcCtD
Valganciclovir—Asthenia—Telmisartan—hypertension	2.17e-05	9.4e-05	CcSEcCtD
Valganciclovir—Pruritus—Enalapril—hypertension	2.17e-05	9.4e-05	CcSEcCtD
Valganciclovir—Anxiety—Lisinopril—hypertension	2.16e-05	9.38e-05	CcSEcCtD
Valganciclovir—Diarrhoea—Clonidine—hypertension	2.16e-05	9.35e-05	CcSEcCtD
Valganciclovir—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—hypertension	2.16e-05	9.34e-05	CcSEcCtD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—APOA1—hypertension	2.15e-05	0.000242	CbGpPWpGaD
Valganciclovir—Nausea—Fosinopril—hypertension	2.15e-05	9.31e-05	CcSEcCtD
Valganciclovir—Discomfort—Lisinopril—hypertension	2.15e-05	9.3e-05	CcSEcCtD
Valganciclovir—Hypotension—Ramipril—hypertension	2.15e-05	9.29e-05	CcSEcCtD
Valganciclovir—Anorexia—Timolol—hypertension	2.14e-05	9.27e-05	CcSEcCtD
Valganciclovir—Pruritus—Telmisartan—hypertension	2.14e-05	9.27e-05	CcSEcCtD
Valganciclovir—Nausea—Eplerenone—hypertension	2.14e-05	9.26e-05	CcSEcCtD
Valganciclovir—Urticaria—Losartan—hypertension	2.13e-05	9.21e-05	CcSEcCtD
Valganciclovir—Dry mouth—Lisinopril—hypertension	2.12e-05	9.2e-05	CcSEcCtD
Valganciclovir—Nausea—Nifedipine—hypertension	2.12e-05	9.19e-05	CcSEcCtD
Valganciclovir—Abdominal pain—Losartan—hypertension	2.12e-05	9.17e-05	CcSEcCtD
Valganciclovir—Body temperature increased—Losartan—hypertension	2.12e-05	9.17e-05	CcSEcCtD
Valganciclovir—Nausea—Verapamil—hypertension	2.11e-05	9.15e-05	CcSEcCtD
Valganciclovir—Asthenia—Captopril—hypertension	2.11e-05	9.14e-05	CcSEcCtD
Valganciclovir—Diarrhoea—Trandolapril—hypertension	2.11e-05	9.12e-05	CcSEcCtD
Valganciclovir—Vomiting—Valsartan—hypertension	2.11e-05	9.12e-05	CcSEcCtD
Valganciclovir—Confusional state—Lisinopril—hypertension	2.1e-05	9.1e-05	CcSEcCtD
Valganciclovir—Diarrhoea—Enalapril—hypertension	2.1e-05	9.09e-05	CcSEcCtD
Valganciclovir—Hypotension—Timolol—hypertension	2.1e-05	9.09e-05	CcSEcCtD
Valganciclovir—Hypersensitivity—Irbesartan—hypertension	2.1e-05	9.08e-05	CcSEcCtD
Valganciclovir—Vomiting—Olmesartan—hypertension	2.1e-05	9.08e-05	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Ramipril—hypertension	2.09e-05	9.06e-05	CcSEcCtD
Valganciclovir—Dizziness—Clonidine—hypertension	2.09e-05	9.04e-05	CcSEcCtD
Valganciclovir—Dermatitis—Valsartan—hypertension	2.09e-05	9.03e-05	CcSEcCtD
Valganciclovir—Oedema—Lisinopril—hypertension	2.08e-05	9.02e-05	CcSEcCtD
Valganciclovir—Anaphylactic shock—Lisinopril—hypertension	2.08e-05	9.02e-05	CcSEcCtD
Valganciclovir—Pruritus—Captopril—hypertension	2.08e-05	9.01e-05	CcSEcCtD
Valganciclovir—Hypersensitivity—Hydrochlorothiazide—hypertension	2.08e-05	9.01e-05	CcSEcCtD
Valganciclovir—Insomnia—Ramipril—hypertension	2.08e-05	9e-05	CcSEcCtD
Valganciclovir—Dermatitis—Olmesartan—hypertension	2.08e-05	8.99e-05	CcSEcCtD
Valganciclovir—Headache—Valsartan—hypertension	2.07e-05	8.98e-05	CcSEcCtD
Valganciclovir—Diarrhoea—Telmisartan—hypertension	2.07e-05	8.96e-05	CcSEcCtD
Valganciclovir—Infection—Lisinopril—hypertension	2.07e-05	8.96e-05	CcSEcCtD
Valganciclovir—Headache—Olmesartan—hypertension	2.06e-05	8.94e-05	CcSEcCtD
Valganciclovir—Paraesthesia—Ramipril—hypertension	2.06e-05	8.93e-05	CcSEcCtD
Valganciclovir—Asthenia—Perindopril—hypertension	2.05e-05	8.87e-05	CcSEcCtD
Valganciclovir—Dyspnoea—Ramipril—hypertension	2.05e-05	8.87e-05	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Timolol—hypertension	2.05e-05	8.86e-05	CcSEcCtD
Valganciclovir—Hypersensitivity—Furosemide—hypertension	2.05e-05	8.86e-05	CcSEcCtD
Valganciclovir—Asthenia—Irbesartan—hypertension	2.04e-05	8.84e-05	CcSEcCtD
Valganciclovir—Somnolence—Ramipril—hypertension	2.04e-05	8.84e-05	CcSEcCtD
Valganciclovir—Thrombocytopenia—Lisinopril—hypertension	2.04e-05	8.83e-05	CcSEcCtD
Valganciclovir—Dizziness—Trandolapril—hypertension	2.04e-05	8.82e-05	CcSEcCtD
Valganciclovir—Tachycardia—Lisinopril—hypertension	2.03e-05	8.8e-05	CcSEcCtD
Valganciclovir—Insomnia—Timolol—hypertension	2.03e-05	8.79e-05	CcSEcCtD
Valganciclovir—Dizziness—Enalapril—hypertension	2.03e-05	8.78e-05	CcSEcCtD
Valganciclovir—Asthenia—Hydrochlorothiazide—hypertension	2.03e-05	8.77e-05	CcSEcCtD
Valganciclovir—Hypersensitivity—Betaxolol—hypertension	2.02e-05	8.77e-05	CcSEcCtD
Valganciclovir—Skin disorder—Lisinopril—hypertension	2.02e-05	8.76e-05	CcSEcCtD
Valganciclovir—Dyspepsia—Ramipril—hypertension	2.02e-05	8.76e-05	CcSEcCtD
Valganciclovir—Pruritus—Perindopril—hypertension	2.02e-05	8.75e-05	CcSEcCtD
Valganciclovir—Paraesthesia—Timolol—hypertension	2.02e-05	8.73e-05	CcSEcCtD
Valganciclovir—Pruritus—Irbesartan—hypertension	2.01e-05	8.72e-05	CcSEcCtD
Valganciclovir—Hyperhidrosis—Lisinopril—hypertension	2.01e-05	8.72e-05	CcSEcCtD
Valganciclovir—Diarrhoea—Captopril—hypertension	2.01e-05	8.71e-05	CcSEcCtD
Valganciclovir—Vomiting—Clonidine—hypertension	2.01e-05	8.69e-05	CcSEcCtD
Valganciclovir—Dyspnoea—Timolol—hypertension	2e-05	8.67e-05	CcSEcCtD
Valganciclovir—Dizziness—Telmisartan—hypertension	2e-05	8.66e-05	CcSEcCtD
Valganciclovir—Pruritus—Hydrochlorothiazide—hypertension	2e-05	8.65e-05	CcSEcCtD
Valganciclovir—Decreased appetite—Ramipril—hypertension	2e-05	8.65e-05	CcSEcCtD
Valganciclovir—Somnolence—Timolol—hypertension	2e-05	8.64e-05	CcSEcCtD
Valganciclovir—Asthenia—Furosemide—hypertension	1.99e-05	8.63e-05	CcSEcCtD
Valganciclovir—Dermatitis—Clonidine—hypertension	1.99e-05	8.61e-05	CcSEcCtD
Valganciclovir—Anorexia—Lisinopril—hypertension	1.99e-05	8.6e-05	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Ramipril—hypertension	1.98e-05	8.59e-05	CcSEcCtD
Valganciclovir—Fatigue—Ramipril—hypertension	1.98e-05	8.57e-05	CcSEcCtD
Valganciclovir—Headache—Clonidine—hypertension	1.98e-05	8.56e-05	CcSEcCtD
Valganciclovir—Dyspepsia—Timolol—hypertension	1.98e-05	8.56e-05	CcSEcCtD
Valganciclovir—Hypersensitivity—Losartan—hypertension	1.97e-05	8.55e-05	CcSEcCtD
Valganciclovir—Asthenia—Betaxolol—hypertension	1.97e-05	8.54e-05	CcSEcCtD
Valganciclovir—Nausea—Valsartan—hypertension	1.97e-05	8.52e-05	CcSEcCtD
Valganciclovir—Pruritus—Furosemide—hypertension	1.96e-05	8.51e-05	CcSEcCtD
Valganciclovir—Constipation—Ramipril—hypertension	1.96e-05	8.51e-05	CcSEcCtD
Valganciclovir—Nausea—Olmesartan—hypertension	1.96e-05	8.48e-05	CcSEcCtD
Valganciclovir—Vomiting—Trandolapril—hypertension	1.96e-05	8.48e-05	CcSEcCtD
Valganciclovir—Diarrhoea—Perindopril—hypertension	1.95e-05	8.46e-05	CcSEcCtD
Valganciclovir—Decreased appetite—Timolol—hypertension	1.95e-05	8.45e-05	CcSEcCtD
Valganciclovir—Vomiting—Enalapril—hypertension	1.95e-05	8.44e-05	CcSEcCtD
Valganciclovir—Diarrhoea—Irbesartan—hypertension	1.95e-05	8.43e-05	CcSEcCtD
Valganciclovir—Hypotension—Lisinopril—hypertension	1.95e-05	8.43e-05	CcSEcCtD
Valganciclovir—Dizziness—Captopril—hypertension	1.94e-05	8.42e-05	CcSEcCtD
Valganciclovir—Pruritus—Betaxolol—hypertension	1.94e-05	8.42e-05	CcSEcCtD
Valganciclovir—Dermatitis—Trandolapril—hypertension	1.94e-05	8.4e-05	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Timolol—hypertension	1.94e-05	8.39e-05	CcSEcCtD
Valganciclovir—Fatigue—Timolol—hypertension	1.94e-05	8.38e-05	CcSEcCtD
Valganciclovir—Dermatitis—Enalapril—hypertension	1.93e-05	8.37e-05	CcSEcCtD
Valganciclovir—Diarrhoea—Hydrochlorothiazide—hypertension	1.93e-05	8.36e-05	CcSEcCtD
Valganciclovir—Headache—Trandolapril—hypertension	1.93e-05	8.35e-05	CcSEcCtD
Valganciclovir—Vomiting—Telmisartan—hypertension	1.92e-05	8.33e-05	CcSEcCtD
Valganciclovir—Asthenia—Losartan—hypertension	1.92e-05	8.32e-05	CcSEcCtD
Valganciclovir—Headache—Enalapril—hypertension	1.92e-05	8.32e-05	CcSEcCtD
Valganciclovir—Pain—Timolol—hypertension	1.92e-05	8.31e-05	CcSEcCtD
Valganciclovir—Dermatitis—Telmisartan—hypertension	1.91e-05	8.25e-05	CcSEcCtD
Valganciclovir—Diarrhoea—Furosemide—hypertension	1.9e-05	8.23e-05	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Lisinopril—hypertension	1.9e-05	8.22e-05	CcSEcCtD
Valganciclovir—Pruritus—Losartan—hypertension	1.89e-05	8.21e-05	CcSEcCtD
Valganciclovir—Headache—Telmisartan—hypertension	1.89e-05	8.21e-05	CcSEcCtD
Valganciclovir—Feeling abnormal—Ramipril—hypertension	1.89e-05	8.2e-05	CcSEcCtD
Valganciclovir—Dizziness—Perindopril—hypertension	1.89e-05	8.18e-05	CcSEcCtD
Valganciclovir—Insomnia—Lisinopril—hypertension	1.88e-05	8.16e-05	CcSEcCtD
Valganciclovir—Dizziness—Irbesartan—hypertension	1.88e-05	8.15e-05	CcSEcCtD
Valganciclovir—Diarrhoea—Betaxolol—hypertension	1.88e-05	8.14e-05	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Ramipril—hypertension	1.88e-05	8.13e-05	CcSEcCtD
Valganciclovir—Nausea—Clonidine—hypertension	1.87e-05	8.12e-05	CcSEcCtD
Valganciclovir—Paraesthesia—Lisinopril—hypertension	1.87e-05	8.1e-05	CcSEcCtD
Valganciclovir—Vomiting—Captopril—hypertension	1.87e-05	8.1e-05	CcSEcCtD
Valganciclovir—Dizziness—Hydrochlorothiazide—hypertension	1.87e-05	8.08e-05	CcSEcCtD
Valganciclovir—Dyspnoea—Lisinopril—hypertension	1.86e-05	8.04e-05	CcSEcCtD
Valganciclovir—Dermatitis—Captopril—hypertension	1.85e-05	8.02e-05	CcSEcCtD
Valganciclovir—Somnolence—Lisinopril—hypertension	1.85e-05	8.02e-05	CcSEcCtD
Valganciclovir—Feeling abnormal—Timolol—hypertension	1.85e-05	8.01e-05	CcSEcCtD
Valganciclovir—Headache—Captopril—hypertension	1.84e-05	7.98e-05	CcSEcCtD
Valganciclovir—SLC15A2—Transmembrane transport of small molecules—ALB—hypertension	1.84e-05	0.000207	CbGpPWpGaD
Valganciclovir—Gastrointestinal pain—Timolol—hypertension	1.84e-05	7.95e-05	CcSEcCtD
Valganciclovir—Dizziness—Furosemide—hypertension	1.84e-05	7.95e-05	CcSEcCtD
Valganciclovir—Dyspepsia—Lisinopril—hypertension	1.83e-05	7.94e-05	CcSEcCtD
Valganciclovir—Diarrhoea—Losartan—hypertension	1.83e-05	7.94e-05	CcSEcCtD
Valganciclovir—Nausea—Trandolapril—hypertension	1.83e-05	7.92e-05	CcSEcCtD
Valganciclovir—Urticaria—Ramipril—hypertension	1.82e-05	7.9e-05	CcSEcCtD
Valganciclovir—Nausea—Enalapril—hypertension	1.82e-05	7.89e-05	CcSEcCtD
Valganciclovir—Dizziness—Betaxolol—hypertension	1.82e-05	7.87e-05	CcSEcCtD
Valganciclovir—Vomiting—Perindopril—hypertension	1.82e-05	7.86e-05	CcSEcCtD
Valganciclovir—Abdominal pain—Ramipril—hypertension	1.82e-05	7.86e-05	CcSEcCtD
Valganciclovir—Body temperature increased—Ramipril—hypertension	1.82e-05	7.86e-05	CcSEcCtD
Valganciclovir—Decreased appetite—Lisinopril—hypertension	1.81e-05	7.84e-05	CcSEcCtD
Valganciclovir—Vomiting—Irbesartan—hypertension	1.81e-05	7.84e-05	CcSEcCtD
Valganciclovir—Dermatitis—Perindopril—hypertension	1.8e-05	7.79e-05	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Lisinopril—hypertension	1.8e-05	7.79e-05	CcSEcCtD
Valganciclovir—Nausea—Telmisartan—hypertension	1.8e-05	7.78e-05	CcSEcCtD
Valganciclovir—Fatigue—Lisinopril—hypertension	1.8e-05	7.78e-05	CcSEcCtD
Valganciclovir—Vomiting—Hydrochlorothiazide—hypertension	1.79e-05	7.77e-05	CcSEcCtD
Valganciclovir—Dermatitis—Irbesartan—hypertension	1.79e-05	7.76e-05	CcSEcCtD
Valganciclovir—Headache—Perindopril—hypertension	1.79e-05	7.75e-05	CcSEcCtD
Valganciclovir—Urticaria—Timolol—hypertension	1.78e-05	7.72e-05	CcSEcCtD
Valganciclovir—Headache—Irbesartan—hypertension	1.78e-05	7.72e-05	CcSEcCtD
Valganciclovir—Pain—Lisinopril—hypertension	1.78e-05	7.71e-05	CcSEcCtD
Valganciclovir—Constipation—Lisinopril—hypertension	1.78e-05	7.71e-05	CcSEcCtD
Valganciclovir—Dermatitis—Hydrochlorothiazide—hypertension	1.78e-05	7.7e-05	CcSEcCtD
Valganciclovir—Body temperature increased—Timolol—hypertension	1.77e-05	7.69e-05	CcSEcCtD
Valganciclovir—Abdominal pain—Timolol—hypertension	1.77e-05	7.69e-05	CcSEcCtD
Valganciclovir—Dizziness—Losartan—hypertension	1.77e-05	7.67e-05	CcSEcCtD
Valganciclovir—Headache—Hydrochlorothiazide—hypertension	1.77e-05	7.66e-05	CcSEcCtD
Valganciclovir—Vomiting—Furosemide—hypertension	1.76e-05	7.64e-05	CcSEcCtD
Valganciclovir—Dermatitis—Furosemide—hypertension	1.75e-05	7.57e-05	CcSEcCtD
Valganciclovir—Vomiting—Betaxolol—hypertension	1.75e-05	7.57e-05	CcSEcCtD
Valganciclovir—Nausea—Captopril—hypertension	1.75e-05	7.57e-05	CcSEcCtD
Valganciclovir—Headache—Furosemide—hypertension	1.74e-05	7.53e-05	CcSEcCtD
Valganciclovir—Dermatitis—Betaxolol—hypertension	1.73e-05	7.5e-05	CcSEcCtD
Valganciclovir—Headache—Betaxolol—hypertension	1.72e-05	7.46e-05	CcSEcCtD
Valganciclovir—Feeling abnormal—Lisinopril—hypertension	1.72e-05	7.43e-05	CcSEcCtD
Valganciclovir—SLC15A1—Transmembrane transport of small molecules—ALB—hypertension	1.7e-05	0.000192	CbGpPWpGaD
Valganciclovir—Gastrointestinal pain—Lisinopril—hypertension	1.7e-05	7.38e-05	CcSEcCtD
Valganciclovir—Vomiting—Losartan—hypertension	1.7e-05	7.38e-05	CcSEcCtD
Valganciclovir—Nausea—Perindopril—hypertension	1.7e-05	7.35e-05	CcSEcCtD
Valganciclovir—Hypersensitivity—Ramipril—hypertension	1.69e-05	7.33e-05	CcSEcCtD
Valganciclovir—Nausea—Irbesartan—hypertension	1.69e-05	7.32e-05	CcSEcCtD
Valganciclovir—Dermatitis—Losartan—hypertension	1.69e-05	7.31e-05	CcSEcCtD
Valganciclovir—Headache—Losartan—hypertension	1.68e-05	7.27e-05	CcSEcCtD
Valganciclovir—Nausea—Hydrochlorothiazide—hypertension	1.68e-05	7.26e-05	CcSEcCtD
Valganciclovir—Urticaria—Lisinopril—hypertension	1.65e-05	7.17e-05	CcSEcCtD
Valganciclovir—Hypersensitivity—Timolol—hypertension	1.65e-05	7.16e-05	CcSEcCtD
Valganciclovir—Nausea—Furosemide—hypertension	1.65e-05	7.14e-05	CcSEcCtD
Valganciclovir—Asthenia—Ramipril—hypertension	1.65e-05	7.14e-05	CcSEcCtD
Valganciclovir—Abdominal pain—Lisinopril—hypertension	1.65e-05	7.13e-05	CcSEcCtD
Valganciclovir—Body temperature increased—Lisinopril—hypertension	1.65e-05	7.13e-05	CcSEcCtD
Valganciclovir—Nausea—Betaxolol—hypertension	1.63e-05	7.07e-05	CcSEcCtD
Valganciclovir—Pruritus—Ramipril—hypertension	1.62e-05	7.04e-05	CcSEcCtD
Valganciclovir—Asthenia—Timolol—hypertension	1.61e-05	6.98e-05	CcSEcCtD
Valganciclovir—Nausea—Losartan—hypertension	1.59e-05	6.89e-05	CcSEcCtD
Valganciclovir—Pruritus—Timolol—hypertension	1.59e-05	6.88e-05	CcSEcCtD
Valganciclovir—Diarrhoea—Ramipril—hypertension	1.57e-05	6.81e-05	CcSEcCtD
Valganciclovir—Diarrhoea—Timolol—hypertension	1.54e-05	6.65e-05	CcSEcCtD
Valganciclovir—Hypersensitivity—Lisinopril—hypertension	1.53e-05	6.65e-05	CcSEcCtD
Valganciclovir—Dizziness—Ramipril—hypertension	1.52e-05	6.58e-05	CcSEcCtD
Valganciclovir—Asthenia—Lisinopril—hypertension	1.49e-05	6.47e-05	CcSEcCtD
Valganciclovir—Dizziness—Timolol—hypertension	1.48e-05	6.43e-05	CcSEcCtD
Valganciclovir—Pruritus—Lisinopril—hypertension	1.47e-05	6.38e-05	CcSEcCtD
Valganciclovir—Vomiting—Ramipril—hypertension	1.46e-05	6.32e-05	CcSEcCtD
Valganciclovir—Dermatitis—Ramipril—hypertension	1.45e-05	6.27e-05	CcSEcCtD
Valganciclovir—Headache—Ramipril—hypertension	1.44e-05	6.23e-05	CcSEcCtD
Valganciclovir—Vomiting—Timolol—hypertension	1.43e-05	6.18e-05	CcSEcCtD
Valganciclovir—Diarrhoea—Lisinopril—hypertension	1.42e-05	6.17e-05	CcSEcCtD
Valganciclovir—Dermatitis—Timolol—hypertension	1.41e-05	6.13e-05	CcSEcCtD
Valganciclovir—Headache—Timolol—hypertension	1.41e-05	6.09e-05	CcSEcCtD
Valganciclovir—Dizziness—Lisinopril—hypertension	1.38e-05	5.96e-05	CcSEcCtD
Valganciclovir—Nausea—Ramipril—hypertension	1.36e-05	5.91e-05	CcSEcCtD
Valganciclovir—Nausea—Timolol—hypertension	1.33e-05	5.78e-05	CcSEcCtD
Valganciclovir—Vomiting—Lisinopril—hypertension	1.32e-05	5.74e-05	CcSEcCtD
Valganciclovir—Dermatitis—Lisinopril—hypertension	1.31e-05	5.68e-05	CcSEcCtD
Valganciclovir—Headache—Lisinopril—hypertension	1.3e-05	5.65e-05	CcSEcCtD
Valganciclovir—Nausea—Lisinopril—hypertension	1.24e-05	5.36e-05	CcSEcCtD
